Insider · CIK 0001818261

Catinazzo Thomas

CIK 0001818261 Name as filed on the most recent filing

Filed as Catinazzo Thomas (48)

67 transaction lines · from 48 filings · filed 2021-04-01 to 2026-08-18 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

67 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2026-08-14 S, Open-market sale Relay Therapeutics, Inc.RLAY 349,734, disposed Open Form 4 filing 0001193125-26-355493
2026-07-28 S, Open-market sale Relay Therapeutics, Inc.RLAY 27,152, disposed Open Form 4 filing 0001193125-26-326144
2026-07-06 S, Open-market sale Relay Therapeutics, Inc.RLAY 331,131, disposed Open Form 4 filing 0001193125-26-298679
2026-06-22 S, Open-market sale Relay Therapeutics, Inc.RLAY 4 lines 3,176,865, disposed Open Form 4 filing 0001193125-26-281061
2026-05-14 S, Open-market sale Relay Therapeutics, Inc.RLAY 227,841, disposed Open Form 4 filing 0001193125-26-224545
2026-04-28 S, Open-market sale Relay Therapeutics, Inc.RLAY 14,376, disposed Open Form 4 filing 0001193125-26-197419
2026-04-09 S, Open-market sale Relay Therapeutics, Inc.RLAY 27,000, disposed Open Form 4 filing 0001193125-26-150044
2026-04-07 S, Open-market sale Relay Therapeutics, Inc.RLAY 230,498, disposed Open Form 4 filing 0001193125-26-150044
2026-03-09 S, Open-market sale Relay Therapeutics, Inc.RLAY 178,233, disposed Open Form 4 filing 0001193125-26-102270
2026-01-28 S, Open-market sale Relay Therapeutics, Inc.RLAY 14,323, disposed Open Form 4 filing 0001193125-26-029403
2026-01-27 S, Open-market sale Relay Therapeutics, Inc.RLAY 105,308, disposed Open Form 4 filing 0001193125-26-029403
2025-10-28 S, Open-market sale Relay Therapeutics, Inc.RLAY 157,931, disposed Open Form 4 filing 0001193125-25-258574
2025-07-29 S, Open-market sale Relay Therapeutics, Inc.RLAY 67,638, disposed Open Form 4 filing 0000950170-25-100366
2025-07-28 S, Open-market sale Relay Therapeutics, Inc.RLAY 6,362, disposed Open Form 4 filing 0000950170-25-100366
2025-04-30 S, Open-market sale Relay Therapeutics, Inc.RLAY 38,829, disposed Open Form 4 filing 0000950170-25-061366
2025-04-29 S, Open-market sale Relay Therapeutics, Inc.RLAY 11,492, disposed Open Form 4 filing 0000950170-25-061366
2025-04-28 S, Open-market sale Relay Therapeutics, Inc.RLAY 2 lines 8,527, disposed Open Form 4 filing 0000950170-25-061366
2025-03-27 S, Open-market sale Relay Therapeutics, Inc.RLAY 2 lines 13,814, disposed Open Form 4 filing 0000950170-25-047725
2025-01-30 S, Open-market sale Relay Therapeutics, Inc.RLAY 91,896, disposed Open Form 4 filing 0000950170-25-011327
2025-01-29 S, Open-market sale Relay Therapeutics, Inc.RLAY 9,596, disposed Open Form 4 filing 0000950170-25-011327
2025-01-28 S, Open-market sale Relay Therapeutics, Inc.RLAY 2 lines 166,847, disposed Open Form 4 filing 0000950170-25-011327
2024-12-27 S, Open-market sale Relay Therapeutics, Inc.RLAY 2 lines 21,491, disposed Open Form 4 filing 0000950170-24-141597
2024-10-29 S, Open-market sale Relay Therapeutics, Inc.RLAY 13,685, disposed Open Form 4 filing 0000950170-24-118982
2024-10-28 S, Open-market sale Relay Therapeutics, Inc.RLAY 2 lines 41,220, disposed Open Form 4 filing 0000950170-24-118982
2024-09-27 S, Open-market sale Relay Therapeutics, Inc.RLAY 2 lines 48,184, disposed Open Form 4 filing 0000950170-24-110810
2024-07-29 S, Open-market sale Relay Therapeutics, Inc.RLAY 2 lines 92,316, disposed Open Form 4 filing 0000950170-24-088815
2024-06-27 S, Open-market sale Relay Therapeutics, Inc.RLAY 2 lines 58,493, disposed Open Form 4 filing 0000950170-24-079689
2024-04-29 S, Open-market sale Relay Therapeutics, Inc.RLAY 10,814, disposed Open Form 4 filing 0000950170-24-050147
2024-03-27 S, Open-market sale Relay Therapeutics, Inc.RLAY 2,680, disposed Open Form 4 filing 0000950170-24-038658
2024-01-29 S, Open-market sale Relay Therapeutics, Inc.RLAY 19,328, disposed Open Form 4 filing 0001209191-24-002472
2023-12-27 S, Open-market sale Relay Therapeutics, Inc.RLAY 3,384, disposed Open Form 4 filing 0001209191-23-059998
2023-10-30 S, Open-market sale Relay Therapeutics, Inc.RLAY 10,233, disposed Open Form 4 filing 0001209191-23-054024
2023-09-27 S, Open-market sale Relay Therapeutics, Inc.RLAY 2,464, disposed Open Form 4 filing 0001209191-23-050863
2023-07-28 S, Open-market sale Relay Therapeutics, Inc.RLAY 19,977, disposed Open Form 4 filing 0001209191-23-043843
2023-06-27 S, Open-market sale Relay Therapeutics, Inc.RLAY 3,563, disposed Open Form 4 filing 0001209191-23-040061
2023-04-28 S, Open-market sale Relay Therapeutics, Inc.RLAY 22,454, disposed Open Form 4 filing 0001209191-23-033419
2023-04-28 S, Open-market sale Relay Therapeutics, Inc.RLAY 9,631, disposed Open Form 4 filing 0001209191-23-026277
2023-03-27 S, Open-market sale Relay Therapeutics, Inc.RLAY 5,330, disposed Open Form 4 filing 0001209191-23-021420
2023-01-30 S, Open-market sale Relay Therapeutics, Inc.RLAY 18,628, disposed Open Form 4 filing 0001209191-23-005700

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
S, Open-market sale
Open-market sale
Relationships on this page
O, Officer
Officer

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 0
  • Open-market sale 67
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Catinazzo Thomas, insider transactions. Retrieved 2026-08-23 from https://ebomi.com/insider/0001818261

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.